These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 11481652)

  • 21. Paratesticular sarcoma in childhood and adolescence. A report from the Intergroup Rhabdomyosarcoma Studies I and II, 1973-1983.
    Raney RB; Tefft M; Lawrence W; Ragab AH; Soule EH; Beltangady M; Gehan EA
    Cancer; 1987 Nov; 60(9):2337-43. PubMed ID: 3440240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary tumor size predicts pathologic findings in the retroperitoneal lymph nodes in patients with paratesticular rhabdomyosarcoma.
    Alanee S; Holland B; Dynda D; Kamel O; Ganai S
    Virchows Arch; 2014 Dec; 465(6):697-701. PubMed ID: 25293343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of surgical excision in chest wall rhabdomyosarcoma: a report from the Children's Oncology Group.
    Hayes-Jordan A; Stoner JA; Anderson JR; Rodeberg D; Weiner G; Meyer WH; Hawkins DS; Arndt CA; Paidas C;
    J Pediatr Surg; 2008 May; 43(5):831-6. PubMed ID: 18485948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Importance of Adequate Surgical Local Control in Fusion-Negative Para-Testicular Rhabdomyosarcoma: Data From the Cooperative Weichteilsarkom Studiengruppe Trials (CWS-96 and CWS-2002P) and the European Soft Tissue Sarcoma Registry (SoTiSaR).
    Martynov I; Sparber-Sauer M; Heinz A; Vokuhl MC; Ebinger M; Gesche J; Münter M; Koscielniak E; Fuchs J; Seitz G;
    Ann Surg Oncol; 2024 Sep; 31(9):6209-6219. PubMed ID: 38879672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved outcome for patients with middle ear rhabdomyosarcoma: a children's oncology group study.
    Hawkins DS; Anderson JR; Paidas CN; Wharam MD; Qualman SJ; Pappo AS; Scott Baker K; Crist WM
    J Clin Oncol; 2001 Jun; 19(12):3073-9. PubMed ID: 11408504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Third Intergroup Rhabdomyosarcoma Study.
    Crist W; Gehan EA; Ragab AH; Dickman PS; Donaldson SS; Fryer C; Hammond D; Hays DM; Herrmann J; Heyn R
    J Clin Oncol; 1995 Mar; 13(3):610-30. PubMed ID: 7884423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paratesticular rhabdomyosarcoma: report from the Italian and German Cooperative Group.
    Ferrari A; Bisogno G; Casanova M; Meazza C; Piva L; Cecchetto G; Zanetti I; Pilz T; Mattke A; Treuner J; Carli M
    J Clin Oncol; 2002 Jan; 20(2):449-55. PubMed ID: 11786573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of radiation therapy parameters on outcome in children treated with radiation therapy for localized parameningeal rhabdomyosarcoma in Intergroup Rhabdomyosarcoma Study Group trials II through IV.
    Michalski JM; Meza J; Breneman JC; Wolden SL; Laurie F; Jodoin M; Raney B; Wharam MD; Donaldson SS
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1027-38. PubMed ID: 15234036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of children with nonmetastatic paratesticular rhabdomyosarcoma: results of the Malignant Mesenchymal Tumors studies (MMT 84 and MMT 89) of the International Society of Pediatric Oncology.
    Stewart RJ; Martelli H; Oberlin O; Rey A; Bouvet N; Spicer RD; Godzinski J; Stevens MC;
    J Clin Oncol; 2003 Mar; 21(5):793-8. PubMed ID: 12610176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Studies I to III.
    Wolden SL; Anderson JR; Crist WM; Breneman JC; Wharam MD; Wiener ES; Qualman SJ; Donaldson SS
    J Clin Oncol; 1999 Nov; 17(11):3468-75. PubMed ID: 10550144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Laparoscopic retroperitoneal lymph node dissection for low-stage testicular cancer.
    Skolarus TA; Bhayani SB; Chiang HC; Brandes SB; Kibel AS; Landman J; Figenshau RS
    J Endourol; 2008 Jul; 22(7):1485-9. PubMed ID: 18613781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcome, Treatment, and Treatment Failures in Patients Suffering Localized Embryonal Paratesticular Rhabdomyosarcoma: Results From the "Cooperative Weichteilsarkom Studiengruppe" Trials CWS-86, -91, -96, and -2002P.
    Seitz G; Fuchs J; Martus P; Klingebiel T; Leuschner I; Schuck A; Dantonello TM; Koscielniak E;
    Ann Surg; 2016 Dec; 264(6):1148-1155. PubMed ID: 27828824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Robot-assisted retroperitoneal lymph node dissection (RA-RPLND) in the adolescent population.
    Glaser AP; Bowen DK; Lindgren BW; Meeks JJ
    J Pediatr Urol; 2017 Apr; 13(2):223-224. PubMed ID: 28262537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What constitutes optimal therapy for patients with rhabdomyosarcoma of the female genital tract?
    Arndt CA; Donaldson SS; Anderson JR; Andrassy RJ; Laurie F; Link MP; Raney RB; Maurer HM; Crist WM
    Cancer; 2001 Jun; 91(12):2454-68. PubMed ID: 11413538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Retroperitoneal lymph node assessment in pediatric paratesticular rhabdomyosarcoma].
    Guérin F; Martelli H
    Bull Cancer; 2020 Jun; 107(6):666-671. PubMed ID: 32303361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alternative approaches to retroperitoneal lymph node dissection for paratesticular rhabdomyosarcoma.
    Mansfield SA; Murphy AJ; Talbot L; Prajapati H; Maller V; Pappo A; Singhal S; Krasin MJ; Davidoff AM; Abdelhafeez A
    J Pediatr Surg; 2020 Dec; 55(12):2677-2681. PubMed ID: 32345499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What comprises appropriate therapy for children/adolescents with rhabdomyosarcoma arising in the abdominal wall? A report from the Intergroup Rhabdomyosarcoma Study Group.
    Beech TR; Moss RL; Anderson JA; Maurer HM; Qualman SJ; Breneman JC; Wiener ES; Crist WM
    J Pediatr Surg; 1999 May; 34(5):668-71. PubMed ID: 10359160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Staging paratesticular rhabdomyosarcoma in the "as low as reasonably achievable" age: the case for PET-CT.
    Burnette JO; Klaassen Z; Hatley RM; Neunert CE; Williams H; Donohoe JM
    Urology; 2013 Jul; 82(1):220-3. PubMed ID: 23352374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction of cyclophosphamide dose for patients with subset 2 low-risk rhabdomyosarcoma is associated with an increased risk of recurrence: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
    Walterhouse DO; Pappo AS; Meza JL; Breneman JC; Hayes-Jordan A; Parham DM; Cripe TP; Anderson JR; Meyer WH; Hawkins DS
    Cancer; 2017 Jun; 123(12):2368-2375. PubMed ID: 28211936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extremity sarcomas: an analysis of prognostic factors from the Intergroup Rhabdomyosarcoma Study III.
    Andrassy RJ; Corpron CA; Hays D; Raney RB; Wiener ES; Lawrence W; Lobe TE; Bagwell C; Maurer HM
    J Pediatr Surg; 1996 Jan; 31(1):191-6. PubMed ID: 8632278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.